1. Home
  2. RBCAA vs DNTH Comparison

RBCAA vs DNTH Comparison

Compare RBCAA & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RBCAA
  • DNTH
  • Stock Information
  • Founded
  • RBCAA 1974
  • DNTH 2015
  • Country
  • RBCAA United States
  • DNTH United States
  • Employees
  • RBCAA N/A
  • DNTH N/A
  • Industry
  • RBCAA Major Banks
  • DNTH Biotechnology: Pharmaceutical Preparations
  • Sector
  • RBCAA Finance
  • DNTH Health Care
  • Exchange
  • RBCAA Nasdaq
  • DNTH Nasdaq
  • Market Cap
  • RBCAA 1.3B
  • DNTH 1.5B
  • IPO Year
  • RBCAA 1998
  • DNTH N/A
  • Fundamental
  • Price
  • RBCAA $65.90
  • DNTH $34.98
  • Analyst Decision
  • RBCAA Hold
  • DNTH Strong Buy
  • Analyst Count
  • RBCAA 1
  • DNTH 11
  • Target Price
  • RBCAA N/A
  • DNTH $65.22
  • AVG Volume (30 Days)
  • RBCAA 25.1K
  • DNTH 526.1K
  • Earning Date
  • RBCAA 10-17-2025
  • DNTH 11-07-2025
  • Dividend Yield
  • RBCAA 2.72%
  • DNTH N/A
  • EPS Growth
  • RBCAA 24.34
  • DNTH N/A
  • EPS
  • RBCAA 6.44
  • DNTH N/A
  • Revenue
  • RBCAA $378,269,000.00
  • DNTH $4,854,000.00
  • Revenue This Year
  • RBCAA $15.62
  • DNTH N/A
  • Revenue Next Year
  • RBCAA N/A
  • DNTH N/A
  • P/E Ratio
  • RBCAA $10.24
  • DNTH N/A
  • Revenue Growth
  • RBCAA 16.59
  • DNTH 17.87
  • 52 Week Low
  • RBCAA $56.79
  • DNTH $13.37
  • 52 Week High
  • RBCAA $80.68
  • DNTH $40.16
  • Technical
  • Relative Strength Index (RSI)
  • RBCAA 34.03
  • DNTH 54.07
  • Support Level
  • RBCAA $65.38
  • DNTH $32.89
  • Resistance Level
  • RBCAA $72.47
  • DNTH $34.50
  • Average True Range (ATR)
  • RBCAA 1.84
  • DNTH 1.72
  • MACD
  • RBCAA -0.34
  • DNTH -0.24
  • Stochastic Oscillator
  • RBCAA 17.37
  • DNTH 41.68

About RBCAA Republic Bancorp Inc.

Republic Bancorp Inc operates as a financial institution that provides both traditional and non-traditional banking products through five reportable segments. It has traditional banking which generates the majority of revenue, Warehouse Lending, Tax Refund Solutions (TRS), Republic Payment Solutions segment, and Republic Credit Solutions (RCS) business segments. The business activities of these segments include retail mortgage and commercial lending, construction and land development lending, internet lending, correspondent and indirect lending and also private banking, treasury management services, internet, and mobile banking, bank acquisitions, short-term revolving credit facilities, fixed-term residential real estate loans and receipt and payment of federal.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies. The company is focused on developing next-generation complement therapeutics for patients living with severe autoimmune and inflammatory diseases. The company is comprised of an experienced team of biotech and pharma executives. The company's pipeline consists of DNTH103 a subcutaneous active C1s antibody.

Share on Social Networks: